![]() |
|
|
Vol. 17, Issue 3, 1141-1153, March 2006
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||




* Karmanos Cancer Institute and Department of Pathology, Wayne State University, Detroit, MI 48201;
Cardiovascular Research Institute, Texas A&M University Health Science Center, Temple, TX 76504;
Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030; and
|| Cell Signaling Technology, Beverly, MA 01915
Submitted December 27, 2004;
Accepted January 3, 2006
Monitoring Editor: Carl-Henrik Heldin
The RasRafmitogen-activated protein kinase cascade is a key growth-signaling pathway, which uncontrolled activation results in transformation. Although the exact mechanisms underlying Raf-1 regulation remain incompletely understood, phosphorylation has been proposed to play a critical role in this regulation. We report here three novel epidermal growth factor-induced in vivo Raf-1 phosphorylation sites that mediate positive feedback Raf-1 regulation. Using mass spectrometry, we identified Raf-1 phosphorylation on three SP motif sites: S289/S296/S301 and confirmed their identity using two-dimensional-phosphopeptide mapping and phosphospecific antibodies. These sites were phosphorylated by extracellular signal-regulated kinase (ERK)-1 in vitro, and their phosphorylation in vivo was dependent on endogenous ERK activity. Functionally, ERK-1 expression sustains Raf-1 activation in a manner dependent on Raf-1 phosphorylation on the identified sites, and S289/296/301A substitution markedly decreases the in vivo activity of Raf-1 S259A. Importantly, the ERK-phosphorylated Raf-1 pool has 4 times higher specific kinase activity than total Raf-1, and its phosphopeptide composition is similar to that of the general Raf-1 population, suggesting that the preexisting, phosphorylated Raf-1, representing the activatable Raf-1 pool, is the Raf-1 subpopulation targeted by ERK. Our study describes the identification of new in vivo Raf-1 phosphorylation sites targeted by ERK and provides a novel mechanism for a positive feedback Raf-1 regulation.
These authors contributed equally to this work.
Address correspondence to: Guri Tzivion (tziviong{at}karmanos.org).
This article has been cited by other articles:
![]() |
A. Baljuls, W. Schmitz, T. Mueller, R. P. Zahedi, A. Sickmann, M. Hekman, and U. R. Rapp Positive Regulation of A-RAF by Phosphorylation of Isoform-specific Hinge Segment and Identification of Novel Phosphorylation Sites J. Biol. Chem., October 3, 2008; 283(40): 27239 - 27254. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Leboeuf, J. E. Baumgartner, M. Benezra, R. Malaguarnera, D. Solit, C. A. Pratilas, N. Rosen, J. A. Knauf, and J. A. Fagin BRAFV600E Mutation Is Associated with Preferential Sensitivity to Mitogen-Activated Protein Kinase Kinase Inhibition in Thyroid Cancer Cell Lines J. Clin. Endocrinol. Metab., June 1, 2008; 93(6): 2194 - 2201. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Muller, M. Obeyesekere, G. B. Mills, and P. T. Ram Network topology determines dynamics of the mammalian MAPK1,2 signaling network: bifan motif regulation of C-Raf and B-Raf isoforms by FGFR and MC1R FASEB J, May 1, 2008; 22(5): 1393 - 1403. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Smolen, D. A. Baxter, and J. H. Byrne Bistable MAP kinase activity: a plausible mechanism contributing to maintenance of late long-term potentiation Am J Physiol Cell Physiol, February 1, 2008; 294(2): C503 - C515. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Li, S. S. Ong, B. Rajwa, V. T. Thieu, R. L. Geahlen, and M. L. Harrison The SH3 Domain of Lck Modulates T-Cell Receptor-Dependent Activation of Extracellular Signal-Regulated Kinase through Activation of Raf-1 Mol. Cell. Biol., January 15, 2008; 28(2): 630 - 641. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Han, S. M. Knoepp, M. A. Hallman, and K. E. Meier RasGRP1 Confers the Phorbol Ester-Sensitive Phenotype to EL4 Lymphoma Cells Mol. Pharmacol., January 1, 2007; 71(1): 314 - 322. [Abstract] [Full Text] [PDF] |
||||